Skip to main content
Equibles

CI INVESTMENTS INC.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1163648 TORONTO, Z4
Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$263,090
-$77,721 QoQ
Shares Held
1,561
-39.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#560
of 774 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CI INVESTMENTS INC. holds $64,191,935 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 744,827 $53,523,268
2 HIMS
Hims & Hers Health, Inc.
 278,004 $9,638,398
3 VTRS
Viatris Inc
 25,314 $401,986
4 UTHR
UNITED THERAPEUTICS Corp
 674 $365,193
5 NBIX
Neurocrine Biosciences Inc
This page 		1,561 $263,090

All Filings in NBIX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $263,090 1,561
2026-03-31 $340,811 2,587
2025-12-31 $387,905 2,735
2025-09-30 $392,502 2,796
2025-06-30 $384,108 3,056
2025-03-31 $435,985 3,942
2024-12-31 $584,766 4,284
2024-09-30 $408,570 3,546
2024-06-30 $367,165 2,667
2024-03-31 $363,832 2,638
2023-12-31 $192,896 1,464
2023-09-30 $195,075 1,734
2023-06-30 $186,525 1,978
2023-03-31 $84,822 838
2022-12-31 $16,841 141
2022-09-30 $14,975 141
2022-06-30 $13,842 142
2022-03-31 $44,437 474
2021-12-31 $42,755 502
2021-09-30 $39,131 408
2020-06-30 $434,930 3,565